Sectoral budgeting brakes German sales increase in 2000
This article was originally published in Clinica
German medical device sales recorded by member companies of the BVMed industry association rose by 4% in 2000, to DM4.4 billion ($2 billion). The sales of the 170 BVMed members were particularly low in the last quarter of the year mainly due to hospitals' and doctors' concerns about exceeding budgets for the year.
You may also be interested in...
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.
It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.